- Aptorum Group (APM) +153%.
- Akanda (AKAN) +113%.
- ImmunoGen (IMGN) +96% surges ~95% as ovarian cancer drug Elahere shows survival benefit in confirmatory trial.
- Kiromic BioPharma, Inc. (KRBP) +59%.
- Akili (AKLI) +52% see Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx Video Game-Based Therapeutic
- GD Culture Group (GDC) +44% shares surge on pricing downsized ~$9.55M stock offering.
- MOGU (MOGU) +31%.
- COMSovereign Holding (COMS) +29%.
- Dermata Therapeutics (DRMA) +19%.
- Sutro Biopharma (STRO) +18%.
- TC Biopharm (TCBP) +17%.
- Windtree Therapeutics (WINT) +13%.
- P3 Health Partners (PIII) +11%.
- Interactive Strength (TRNR) +11%.
- Livent Corporation (LTHM) +10% Q1 earnings call release
- Lichen China (LICN) +9%.
- CytoMed Therapeutics (GDTC) +9%.
- Pearson (PSO) +9%.
- Jayud Global Logistics (JYD) +8%.
- Quhuo (QH) +8%.
- Acumen Pharmaceuticals (ABOS) +7% to Report First Quarter Financial Results on May 9, 2023.
- Mangoceuticals (MGRX) +7%.
- KWESST Micro Systems (KWE) +7%.
- Eli Lilly and Company (LLY) +6% surges after Alzheimer's drug donanemab slows cognitive decline by 35%, brain swelling seen in some.
- Jianzhi Education Technology Group (JZ) +6%.